Integrin alphavbeta3-mediated endocytosis of immobilized fibrinogen by A549 lung alveolar epithelial cells.
Fibrinogen (FBG), together with its polymerized form fibrin, modulates cellular responses during wound repair and tissue remodeling. Thus, we sought to determine whether A549 lung epithelial type II-like cells would endocytose insoluble, surface-bound FBG as a potential mechanism of alveolar matrix remodeling. Surface-bound FBG was endocytosed into either lysosomes or late endosomes by A549 cells through arg-gly-asp-dependent binding to alphavbeta3 but not alpha5beta1 integrin receptors. Soluble FBG added to confluent monolayers of A549 cells was not endocytosed. Unlike the uptake of the extracellular matrix glycoproteins vitronectin and thrombospondin by other cell types, endocytosis of FBG by A549 cells was neither inhibited by heparin nor dependent on binding to cell-surface heparan sulfate proteoglycans. FBG did not colocalize with endocytosed transferrin, whereas dextran showed partial colocalization with FBG in endocytic vesicles, suggesting nonclathrin-mediated endocytosis. Inhibition of actin filament polymerization blocked endocytosis of both dextran and FBG but not transferrin, providing further support that FBG is endocytosed via a nonclathrin pathway. Disruption of actin polymerization inhibited integrin-mediated cell spreading, which contributed to an overall reduction in FBG clearance that was most likely due to reduced cell migration and associated pericellular proteolysis. Trasylol inhibition of extracellular plasmin activity did not inhibit endocytosis of FBG. The endocytosed FBG was degraded to trichloroacetic acid-soluble fragments that showed an electrophoretic pattern distinctly different from plasmin-degraded FBG. Together, these results suggest that endocytosis of matrix-associated FBG by alveolar epithelial cells may be involved in the processes of alveolar tissue repair and matrix remodeling.
Odrljin
T M
TM
Departments of Medicine/Vascular Medicine Unit, Microbiology and Immunology, Center for Oral Biology, Pediatrics, and Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA.
Haidaris
C G
CG
Lerner
N B
NB
Simpson-Haidaris
P J
PJ
D002460:Cell Line; D002966:Clathrin / Q000378:metabolism; D004705:Endocytosis / Q000187:drug effects / Q000502:physiology*; D004847:Epithelial Cells / Q000378:metabolism; D005340:Fibrinogen / Q000378:metabolism*; D005341:Fibrinolysin / Q000378:metabolism / Q000494:pharmacology; D006493:Heparin / Q000031:analogs & derivatives / Q000378:metabolism; D006801:Humans; D016023:Integrins / Q000378:metabolism; D008247:Lysosomes / Q000378:metabolism; D009842:Oligopeptides / Q000494:pharmacology; D010447:Peptide Hydrolases / Q000378:metabolism / Q000494:pharmacology; D011499:Protein Processing, Post-Translational / Q000187:drug effects; D011509:Proteoglycans / Q000378:metabolism; D011650:Pulmonary Alveoli / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D019030:Receptors, Vitronectin / Q000378:metabolism*
D002966:Clathrin; D016023:Integrins; D009842:Oligopeptides; D011509:Proteoglycans; D019030:Receptors, Vitronectin; C036090:heparin proteoglycan; C094340:integrin alphavbeta1; C047981:arginyl-glycyl-aspartic acid; D005340:Fibrinogen; D006493:Heparin; D010447:Peptide Hydrolases; D005341:Fibrinolysin